News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,363 Results
Type
Article (22313)
Company Profile (38)
Press Release (356012)
Multimedia
Podcasts (31)
Webinars (7)
Section
Business (119499)
Career Advice (858)
Deals (20193)
Drug Delivery (65)
Drug Development (57020)
Employer Resources (104)
FDA (9274)
Job Trends (8282)
News (204894)
Policy (18081)
Tag
Academia (1565)
Accelerated approval (5)
Adcomms (18)
Allergies (71)
Alliances (27513)
ALS (63)
Alzheimer's disease (950)
Antibody-drug conjugate (ADC) (77)
Approvals (9307)
Artificial intelligence (149)
Autoimmune disease (11)
Automation (9)
Bankruptcy (155)
Best Places to Work (6993)
BIOSECURE Act (10)
Biosimilars (45)
Biotechnology (32)
Bladder cancer (55)
Brain cancer (16)
Breast cancer (187)
Cancer (1548)
Cardiovascular disease (110)
Career advice (720)
Career pathing (14)
CAR-T (103)
Cell therapy (283)
Cervical cancer (14)
Clinical research (46998)
Collaboration (523)
Compensation (98)
Complete response letters (9)
COVID-19 (2474)
CRISPR (25)
C-suite (166)
Cystic fibrosis (68)
Data (1634)
Decentralized trials (1)
Denatured (9)
Depression (22)
Diabetes (180)
Diagnostics (3718)
Digital health (9)
Diversity (4)
Diversity, equity & inclusion (34)
Drug discovery (70)
Drug pricing (55)
Drug shortages (8)
Duchenne muscular dystrophy (52)
Earnings (56224)
Editorial (23)
Employer branding (14)
Employer resources (92)
Events (48671)
Executive appointments (454)
FDA (10223)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (461)
Gene editing (67)
Generative AI (11)
Gene therapy (197)
GLP-1 (388)
Government (3210)
Grass and pollen (5)
Guidances (128)
Healthcare (10510)
Huntington's disease (11)
IgA nephropathy (16)
Immunology and inflammation (65)
Indications (23)
Infectious disease (2610)
Inflammatory bowel disease (86)
Inflation Reduction Act (5)
Influenza (55)
Intellectual property (55)
Interviews (151)
IPO (11224)
IRA (24)
Job creations (1649)
Job search strategy (620)
Kidney cancer (8)
Labor market (8)
Layoffs (291)
Leadership (12)
Legal (3021)
Liver cancer (50)
Lung cancer (229)
Lymphoma (112)
Machine learning (4)
Management (35)
Manufacturing (198)
MASH (35)
Medical device (7261)
Medtech (7262)
Mergers & acquisitions (9329)
Metabolic disorders (418)
Multiple sclerosis (62)
NASH (7)
Neurodegenerative disease (57)
Neuropsychiatric disorders (8)
Neuroscience (1287)
NextGen: Class of 2025 (3332)
Non-profit (2765)
Now hiring (7)
Obesity (213)
Opinion (119)
Ovarian cancer (62)
Pain (53)
Pancreatic cancer (68)
Parkinson's disease (100)
Partnered (11)
Patents (125)
Patient recruitment (87)
Peanut (40)
People (31693)
Pharmaceutical (16)
Pharmacy benefit managers (2)
Phase I (15474)
Phase II (20667)
Phase III (15127)
Pipeline (1051)
Policy (93)
Postmarket research (1570)
Preclinical (5213)
Press Release (34)
Prostate cancer (66)
Psychedelics (12)
Radiopharmaceuticals (150)
Rare diseases (247)
Real estate (2795)
Recruiting (36)
Regulatory (13316)
Reports (27)
Research institute (1505)
Resumes & cover letters (135)
Rett syndrome (5)
RNA editing (4)
RSV (50)
Schizophrenia (36)
Series A (75)
Series B (53)
Service/supplier (2)
Sickle cell disease (34)
Special edition (3)
Spinal muscular atrophy (93)
Sponsored (20)
Startups (1953)
Stomach cancer (8)
Supply chain (41)
Tariffs (25)
The Weekly (21)
Vaccines (818)
Venture capitalists (18)
Weight loss (112)
Women's health (21)
Worklife (6)
Date
Today (154)
Last 7 days (596)
Last 30 days (1860)
Last 365 days (19666)
2025 (6968)
2024 (21171)
2023 (24242)
2022 (32502)
2021 (35022)
2020 (32666)
2019 (25982)
2018 (19907)
2017 (19455)
2016 (17612)
2015 (21294)
2014 (15623)
2013 (11883)
2012 (12684)
2011 (13493)
2010 (11984)
Location
Africa (531)
Alabama (38)
Alaska (5)
Arizona (68)
Arkansas (5)
Asia (24944)
Australia (4549)
California (3599)
Canada (1204)
China (331)
Colorado (162)
Connecticut (143)
Delaware (101)
Europe (54726)
Florida (559)
Georgia (125)
Idaho (31)
Illinois (266)
India (17)
Indiana (186)
Iowa (4)
Japan (127)
Kansas (84)
Kentucky (11)
Louisiana (9)
Maine (51)
Maryland (621)
Massachusetts (2519)
Michigan (125)
Minnesota (207)
Mississippi (2)
Missouri (44)
Montana (22)
Nebraska (11)
Nevada (47)
New Hampshire (39)
New Jersey (1184)
New Mexico (19)
New York (1130)
North Carolina (607)
North Dakota (8)
Northern California (1592)
Ohio (97)
Oklahoma (6)
Oregon (13)
Pennsylvania (830)
Puerto Rico (11)
Rhode Island (17)
South America (661)
South Carolina (13)
South Dakota (1)
Southern California (1399)
Tennessee (43)
Texas (497)
United States (13774)
Utah (114)
Virginia (88)
Washington D.C. (36)
Washington State (357)
West Virginia (1)
Wisconsin (31)
378,363 Results for "international aids vaccine initiative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
May 8, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Is the New HHS Vaccine Requirement Anti-Vaccine Activism Disguised as Policy?
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for vaccines and sought greater clarity: “I don’t know what they’re talking about.”
May 7, 2025
·
6 min read
·
Heather McKenzie
IN PARTNERSHIP WITH DIA
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
May 8, 2025
·
1 min read
·
Lori Ellis
Press Releases
SK bioscience Joins Korea’s National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats
May 7, 2025
·
4 min read
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
March 12, 2025
·
5 min read
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
February 25, 2025
·
5 min read
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
Kennedy is planning modifications to the Vaccines Adverse Event Reporting System to identify whether vaccines contribute to an unstated problem. The reporting system is at the heart of the departure of CBER head Peter Marks.
April 17, 2025
·
2 min read
·
Tristan Manalac
Editorial
RFK Jr. Is Driving a Wedge Into Already Polarized Vaccine Conversations
When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and Human Services secretary are bringing down the hammer. What happens when there is no middle ground?
May 1, 2025
·
7 min read
·
Jef Akst
1 of 37,837
Next
